MAGE-B4 Activators
MAGE-B4 Activators encompass a spectrum of compounds that indirectly enhance the functional activity of MAGE-B4 by modulating various cellular signaling pathways. Forskolin, by elevating intracellular cAMP, activates protein kinase A (PKA), which is known to phosphorylate substrates that could interact with and enhance MAGE-B4 activity within its signaling pathway. Ionomycin, through its action as a calcium ionophore, increases intracellular calcium concentrations, potentially activating calcium/calmodulin-dependent kinases which may influence the activity of MAGE-B4-linked proteins. Phorbol 12-myristate 13-acetate (PMA) and Bisindolylmaleimide I, through their modulation of protein kinase C (PKC) isoforms, can lead to altered signaling cascades, thereby indirectly enhancing MAGE-B4 activity by affecting interacting proteins or pathways.
Epigallocatechin gallate (EGCG) and Staurosporine, although functioning primarily as kinase inhibitors, can shift cellular signaling dynamics to favor the activation of pathways where MAGE-B4 is involved. The cAMP analog Dibutyryl-cAMP (db-cAMP) and the beta-adrenergic agonist Isoproterenol both act to raise cAMP levels, leading to PKA activation and potential enhancement of MAGE-B4 signaling. Sphingosine-1-phosphate (S1P) engages G-protein-coupled receptors and activates downstream pathways that may enhance MAGE-B4 activity. LY294002, as a PI3K inhibitor, can indirectly activate compensatory pathways that enhance MAGE-B4 function. Similarly, SKF-96365 and Retinoic Acid, although they influence calcium signaling and gene expression respectively, may lead to cellular changes that enhance the functional activity of MAGE-B4 through indirect interactions with its signaling network.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to increased levels of cAMP. Elevated cAMP activates PKA, which can phosphorylate and enhance the activity of proteins involved in the signaling pathways that MAGE-B4 is a part of, thus indirectly enhancing MAGE-B4 function. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations. This can activate calcium/calmodulin-dependent protein kinases, which may then impact the phosphorylation state and activity of MAGE-B4, thereby indirectly enhancing its function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is involved in various signaling cascades. PKC activation can lead to the phosphorylation of downstream proteins that are part of MAGE-B4-related pathways, indirectly increasing MAGE-B4 activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist which activates adenyl cyclase, subsequently raising cAMP levels, leading to the activation of PKA. PKA may phosphorylate target proteins that interact with or regulate MAGE-B4, thereby enhancing its activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit certain protein kinases. By inhibiting competitive signaling pathways, it may shift the equilibrium toward pathways that activate MAGE-B4, thus indirectly enhancing its functional activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can influence gene expression through its receptors. Although it primarily regulates transcription, it can also impact downstream signaling proteins that interact with MAGE-B4, potentially enhancing its activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cAMP analog that readily enters cells and activates PKA. Activation of PKA can lead to changes in the phosphorylation state of proteins within MAGE-B4's signaling pathway, enhancing MAGE-B4 activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P binds to its G-protein-coupled receptors, which can activate downstream signaling cascades, including those involving kinases that may regulate MAGE-B4 activity, thus leading to its enhancement. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, and by inhibiting PI3K, it alters downstream signaling pathways. This could indirectly lead to the activation of compensatory pathways that enhance MAGE-B4 activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor, which, by inhibiting certain kinases, may relieve negative regulatory influences on pathways involving MAGE-B4, thus potentially enhancing its activity. | ||||||